Hawaii 2024 Regular Session

Hawaii House Bill HR47

Introduced
3/5/24  
Refer
3/8/24  
Introduced
3/5/24  

Caption

Urging The Department Of Education To Supply All Classrooms With Narcan Or Another Type Of Naloxone By September 1, 2024.

Impact

If enacted, HR47 would directly impact school safety regulations regarding the availability of lifesaving medications within educational institutions. This measure reflects a growing acknowledgment of the opioid crisis and the role that schools can play in safeguarding students' well-being. By mandating that classrooms are equipped with naloxone, the resolution seeks to provide immediate access to antidotes during emergencies, potentially saving lives and fostering a proactive approach to health risks associated with substance abuse among youths.

Summary

House Resolution 47 (HR47) urges the Department of Education in Hawaii to ensure that all classrooms are equipped with Narcan or another form of naloxone by September 1, 2024. This resolution is driven by the alarming statistics provided by the National Institute on Drug Abuse, which reported over eighty thousand opioid overdose deaths in 2020. The use of naloxone, an opioid antagonist with no psychoactive effects, has been widely recognized for its efficacy in reversing opioid overdoses. The recommended placement of naloxone in public school classrooms aims to prevent fatalities from accidental overdoses among students, potentially averting tragic outcomes through timely intervention.

Contention

While the resolution emphasizes the necessity of equipping schools with naloxone, it may also engender discussions surrounding the adequacy of training for staff on how to administer the medication effectively. Additionally, there may be points of contention regarding the implications of such a policy on overall school health programs and budgeting for the provision of naloxone. Stakeholders may debate the best course of action to integrate this initiative within existing health and safety protocols without overwhelming the educational framework.

Companion Bills

HI HCR64

Same As Urging The Department Of Education To Supply All Classrooms With Narcan Or Another Type Of Naloxone By September 1, 2024.

Previously Filed As

HI HCR64

Urging The Department Of Education To Supply All Classrooms With Narcan Or Another Type Of Naloxone By September 1, 2024.

HI SCR113

Urging The Department Of Education To Supply All Classrooms With Narcan Or Another Type Of Naloxone By September 1, 2024.

HI SR95

Urging The Department Of Education To Supply All Classrooms With Narcan Or Another Type Of Naloxone By September 1, 2024.

HI SCR64

Urging The State And Counties To Prioritize And Direct All Available Resources To Supporting Coordinated Interagency Collaboration And Public-private Partnerships Aimed At Addressing The Ongoing Fentanyl Epidemic.

HI SR52

Urging The State And Counties To Prioritize And Direct All Available Resources To Supporting Coordinated Interagency Collaboration And Public-private Partnerships Aimed At Addressing The Ongoing Fentanyl Epidemic.

HI HR1283

Supporting the designation of June 6, 2024, as National Naloxone Awareness Day.

HI HR476

Supporting the designation of June 6, 2023, as National Naloxone Awareness Day.

HI SR35

Urges FDA to make naloxone available over the counter.

HI AR90

Urges FDA to make naloxone available over the counter.

HI SB641

Public health: alcohol and drug programs: naloxone.

Similar Bills

CA AB2256

Law enforcement agencies: opioid antagonist.

CA AB24

Emergency response: opioid antagonist kits.

HI HB310

Relating To Opioid Antagonists.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

CA AB1166

Liability for opioid antagonist administration.

CA SB472

Pupil health: opioid overdose reversal medication.

MI HB5077

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

MS SB2442

Emergency Response and Overdose Prevention Act; amend to expand the distribution and use of opioid antagonists.